Clinical Trials · NCT00353834
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Joslin Diabetes Center
- Enrollment
- 72
- Start date
- Aug 2006
- Locations
- 1 site, United States
- Primary endpoint
- The Primary Endpoint Was the Change in FMD at the End of the Study Compared to Baseline Measurements in Subjects Treated With Exenatide Compared to Subjects Treated With Lantus.